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ABSTRACT 
 
 Pediatric OCD is frequently complicated by co-occurrences with ADHD, mood 
and anxiety disorders. Although each of these disorders is associated with impaired self-
regulation, there has been little examination of impaired self-regulation (i.e., 
dysregulation) in youth with OCD. Dysregulation is characterized by affective, 
behavioral and cognitive problems, and can be assessed using the Child Behavior 
Checklist-Dysregulation Profile (CBCL-DP). Dysregulation may help account for the 
varied yet related findings identified for symptom severity, impairment and treatment 
outcome in pediatric OCD. This study examined the role of dysregulation on symptom 
severity, impairment and treatment outcome in a large sample of youth with OCD.  
A total of 144 youth with primary OCD participated in this study. Clinicians 
administered the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS), 
Clinical Global Impression of Severity (CGI-S) and a 13-item scale of family 
accommodation. Children completed the Multidimensional Anxiety Scale for Children 
(MASC), and the Child Depression Inventory (CDI). Parents completed the CBCL, with 
both children and parents completing parallel versions of the Child OCD Impact Scale 
(COIS-C/P). Within this sample, 97 of these youth received exposure-based CBT and 
completed the same assessment battery along with the Clinical Global Impression of 
Improvement (CGI-I) after treatment.   
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Twenty-nine youth (20%) with OCD met categorical criteria for dysregulation. 
Dysregulated youth had greater obsessive-compulsive symptom severity, depressive 
mood, and exhibited greater rates of family accommodation and impairment than children 
without dysregulation. Hierarchical regressions revealed that the level of dysregulation 
predicted child-and-parent rated impairment, above and beyond obsessive-compulsive 
severity. Additionally, dysregulation predicted clinician-rated family accommodation 
above and beyond obsessive-compulsive severity. When examining treatment outcome to 
exposure-based CBT, a logistic regression indicated that baseline dysregulation did not 
predict treatment responder status. Although not predicting treatment response, it was 
found that youth who discontinued treatment (18%) had significantly higher 
dysregulation than youth who completed treatment (p < .02). For youth who completed 
exposure-based CBT, a significant decrease in obsessive-compulsive symptom severity 
and dysregulation was observed (p < .01).  
Collectively, these findings suggest that youth with OCD and dysregulation 
experience more severe symptoms and have greater impairment than youth with more 
regulated functioning. As dysregulation was associated with treatment discontinuation, 
dysregulated youth with OCD may require more individualized interventions to treat 
dysregulated behavior prior to receiving exposure-based CBT. For youth who complete 
treatment, exposure-based CBT reduces obsessive-compulsive symptom severity and its 
benefits generalize to reductions in dysregulated behaviors as well.   
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INTRODUCTION 
Over the past several decades, considerable advancements have been made in the 
conceptualization, assessment (Lewin & Piacentini, 2010), and treatment (Kircanski, 
Peris, & Piacentini, 2011; Mancuso, Faro, Joshi, & Geller, 2010) of pediatric obsessive-
compulsive disorder (OCD). Despite this progress, many understudied factors remain that 
can influence clinical presentation and treatment outcomes. Among these factors, 
dysregulation may play an influential role in the clinical presentation and treatment 
outcome of youth with OCD. Dysregulation is a construct that is pertinent among youth 
with psychopathology (Althoff, Verhulst, Rettew, Hudziak, & van der Ende, 2010). 
While dysregulation has been examined in clinical and non-clinical samples, there has 
been no study of its role in pediatric OCD. An examination of dysregulation in youth 
with OCD is essential as dysregulation may account for more severe psychopathology, 
elevated levels of impairment and attenuate treatment outcome to cognitive behavioral 
therapy (CBT).  
The present study examines dysregulation in a large sample of youth with OCD 
through four primary objectives. First, this study will examine whether children with 
OCD who meet categorical criteria for dysregulation exhibit more severe 
psychopathology than children with OCD who do not meet dysregulation criteria. 
Second, this study will investigate the relationship between dysregulation, severity and 
impairment reported by clinicians, parents and children.  Third, this study will examine 
whether baseline levels of dysregulation predict treatment outcome. Lastly, this study 
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will examine the change in dysregulation levels after CBT. In addition to providing the 
first known report of dysregulation in pediatric OCD, findings from an examination of 
dysregulation potential influence on treatment outcomes carries important implications 
for all youth presenting with dysregulation who would likely receive CBT.   
Dysregulation 
A key developmental process in childhood is the acquisition of adaptive self-
regulation of emotions and behaviors (Cole, Martin, & Dennis, 2004). Self-adaptive 
regulation is integral to successful functioning across multiple situations and contexts. 
When successfully utilized, dynamic self-regulation facilitates numerous processes (e.g., 
focus attention, promote problem solving, supportive relationship). Indeed the ability to 
adjust internal processes (e.g., thoughts, emotions) to environmental contexts is central in 
early childhood mental health (Blair, 2002).  Conversely, when lacking self-regulation, 
youth can experience detrimental effects (e.g., disrupted attention, interference with 
problem solving, troubled relationships) which may contribute to the later development 
of psychopathology.   
Self-regulation is divided into affective, behavioral, and cognitive components 
(Fitzsimons & Bargh, 2004). When self-regulation is impaired in youth, dysregulation 
can be observed. Stated differently, dysregulation is a disorder of self-regulation across 
the multiple domains of affect, behavior and cognition. As dysregulation is the 
dysfunction of the components of self-regulation, rather than dysfunction of a single 
psychiatric domain, manifestations of dysregulated behaviors are heterogeneous in 
presentation. For example, affective components of dysregulation can manifest in youth 
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as severe anxiety or depressed moods. Behavioral components may be exhibited in youth 
as impulsivity, agitated behaviors, irritability, restlessness and aggressive actions. 
Cognitive components of dysregulation can be identified in youth as inattention. 
Dysregulation likely has multiple factors contributing to its development spanning 
genetic contributions, dysfunctional brain circuits, and environmental factors. While 
intriguing, the underlying development of dysregulation is beyond the scope of this 
current manuscript (see Cole & Deater-Deckard, 2009 or Cole et al., 2004 for a review).  
Across clinically- and non-clinically referred youth, dysregulation varies in its 
frequency and severity, which presents diagnostic challenges for practitioners and 
researchers. For example, the Diagnostic and Statistical Manual of Mental Disorders 
Fourth Edition-Text Revision (DSM-IV-TR) (American Psychiatric Association [APA], 
2000) does not include dysregulation as a diagnostic category. This may stem from the 
heterogeneous presentation of dysregulation in youth. As there is a lack of formal 
recognition of dysregulation,  youth with dysregulation are left to be described using a 
variety of terms like explosive,  mood labile or highly-comorbid (Carlson, 2007). Indeed 
many of these youth were even classified as having a broad phenotype of pediatric 
bipolar disorder (Leibenluft, Charney, Towbin, Bhangoo, & Pine, 2003) or as 
experiencing severe mood dysregulation (Brotman et al., 2006). This variability in 
description can cause difficulties for researchers and clinicians in both consistent 
recognition and treatment of these youth. Without a formal approach to categorizing 
dysregulation, researchers rely on various methods to study and quantify dysregulation in 
youth. As methods (e.g., rating scales, structured interviews) differ across studies, results 
from one sample do not necessarily generalize to another. The inability to categorize 
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youth exhibiting dysregulated behaviors may result in inappropriate classification with 
other disorders that share related behaviors (e.g., ADHD, bipolar disorder), and in turn 
may lead to inappropriate treatment recommendations. For example, over the past decade 
there has been a noticeable increase in the diagnosis of pediatric bipolar disorder 
(Leibenluft, 2008; Moreno et al., 2007). As some clinicians and researchers believe that 
mania presents as persistent non-episodic severe irritability in youth (Biederman, 1998; 
Biederman et al., 2004), confusion between phenotypic symptoms of pediatric bipolar 
and severe irritability independent of pediatric bipolar may result in the misdiagnosis or 
over-diagnosis of the disorder. Consequently, children receiving this diagnostic 
classification may receive inappropriate treatment for their conditions (e.g., antipsychotic 
medication) that may have limited efficacy and/or safety risks (Correll et al., 2009). 
The ambiguity in describing youth with dysregulation may be alleviated through 
the use of quantitative, behavioral rating scales. Specifically, the application of rating 
scales can provide a metric to quantify dysregulation severity, offer a dimensional 
approach beyond broad categorizations, and assist in generalizing findings across 
research samples. Moreover, rating scales can facilitate the accurate and consistent 
identification of dysregulation in youth. One such rating scale is the Child Behavior 
Checklist (CBCL) (Achenbach, 1991; Achenbach & Rescorla, 2001). The CBCL is a 
well-studied, empirically derived parent-rated scale that measures general child and 
adolescent psychopathology. The CBCL does not require clinician training, and thus is 
less likely to be affected by clinical experience or bias. Moreover, the CBCL has a 
profile, referred to as the CBCL-Dysregulation Profile (CBCL-DP), which is defined by 
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deviance on the CBCL syndrome scales of Anxious/Depressed (affective), Aggressive 
Behavior (behavioral) and Inattention (cognitive).  
Using the CBCL-DP as an index, approximately 1.0-3.5% of youth in 
epidemiological studies (Althoff et al., 2010; Hudziak, Althoff, Derks, Faraone, & 
Boomsma, 2005), 6-7% of child psychiatric clinical samples (Holtmann, Becker, 
Banaschewski, Rothenberger, & Roessner, 2011; Holtmann, Goth, Wockel, Poustka, & 
Bolte, 2008), and 10-44% of children with ADHD, (Spencer et al., 2011; Volk & Todd, 
2007) meet criteria for dysregulation. Although there is limited information on the 
development of dysregulation in these samples, available research suggests the 
involvement of additive genetic and environmental factors (Althoff, Rettew, Faraone, 
Boomsma, & Hudziak, 2006; Boomsma et al., 2006; Hudziak et al., 2005). The construct 
of dysregulation appears to be stable across time and age suggesting that children who 
meet criteria continue to exhibit these qualities throughout adulthood (Boomsma et al., 
2006; Meyer et al., 2009). Thus, dysregulation does not appear to be a byproduct of a 
developmental stage (e.g., adolescence), but rather appears to be a relatively stable trait 
of impaired self-regulation. Indeed, higher levels of dysregulation in youth are associated 
with the later development of mental health problems such as substance abuse, 
personality disorders and suicidality (Meyer et al., 2009). In youth with ADHD, the 
presence of dysregulation predicts the emergence of personality disorders in late 
adolescence and early adulthood (Volk & Todd, 2007). Although some researchers 
purported that the CBCL-DP is indicative of a specific diagnosis (e.g., pediatric bipolar 
disorder; Biederman, Wozniak, Kiely, & Ablon, 1995), the CBCL-DP appears to be an 
indicator of disordered self-regulation and impaired functioning (Ayer et al., 2009; Meyer 
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et al., 2009). In addition to severe psychopathology, the CBCL-DP has consistently been 
associated with considerable psychosocial impairment on global assessments of 
functioning in both cross-sectional and longitudinal studies (Biederman et al., 2009; 
Meyer et al., 2009). Given its association with the later development of severe 
psychopathology and impairment, an examination of dysregulation may prove useful in 
clinical populations of youth.  Specifically for youth with OCD, an examination of 
dysregulation may account for the variable findings observed across studies for symptom 
severity, functional impairment and attenuated treatment outcome.   
Pediatric Obsessive Compulsive Disorder 
Obsessive-compulsive disorder (OCD) is a heterogeneous condition characterized 
by the presence of obsessions and/or compulsions that are time-consuming and cause 
distress.  Obsessions are recurrent thoughts, impulses, or images that are experienced as 
inappropriate, intrusive, and distressing. In response to obsessions, individuals with OCD 
perform repetitive behaviors, rituals or mental acts referred to as compulsions. 
Compulsions serve to neutralize fear associated with the obsession, thereby providing 
temporary relief.  This impairing condition affects 1-2% of children (Douglass, Moffitt, 
Dar, & McGee, 1995; Flament et al., 1988) and often results in considerable impairment 
(Piacentini, Bergman, Keller, & McCracken, 2003; Piacentini, Peris, Bergman, Chang, & 
Jaffer, 2007) and a diminished quality of life (Lack et al., 2009). A definitive etiological 
account  of OCD is not yet known; however, multiple determinants including 
neurobiology (Maia, Cooney, & Peterson, 2008), genetics (Pauls, 2010), immunobiology 
(Murphy, Kurlan, & Leckman, 2010), dysfunctional cognitions (Rachman, 1997) and 
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behavioral conditioning (Mowrer, 1960) are implicated in its development and 
maintenance. For children, symptoms usually develop in early school age years, with a 
marked increase in symptom severity in adolescence (Bloch et al., 2009; Geller et al., 
2001). Symptoms developing in childhood are more frequently observed in boys than 
girls (Hanna, 1995) with the gender differential balancing into adulthood (Farrell, Barrett, 
& Piacentini, 2006; Ruscio, Stein, Chiu, & Kessler, 2010).  
Obsessive-compulsive disorder frequently co-occurs with other mental health 
conditions, with up to 90% of cases having at least one comorbid disorder (Ruscio et al., 
2010; Storch et al., 2008a). Children and adolescents with OCD frequently present with 
co-occurring non-OCD anxiety disorders such as separation anxiety disorder (16-56%), 
generalized anxiety disorder (39-48%), social phobia (14-38%); as well as externalizing 
disorders such as attention-deficit hyperactivity disorder (ADHD; 10-51%) and 
oppositional defiant disorder (ODD; 15-51%) (Farrell et al., 2006; Geller et al., 2001; 
Masi et al., 2010). Similarly, youth with OCD often present with mood disorders like 
major depressive disorder (27-62%) (Geller et al., 2001; Masi et al., 2010) and bipolar 
disorder (15-34%) (Joshi et al., 2010; Masi et al., 2010). 
Impaired Self-Regulation in OCD 
Traditionally conceptualized as an anxiety disorder, OCD is also inherently a 
disorder of self-regulation. Its hallmark symptoms (obsessions and compulsions) are 
defined by an inability to inhibit repetitive thoughts and behaviors. Moreover, many of 
the comorbid conditions associated with OCD are also disorders of self-regulation (e.g., 
ADHD, ODD, non-OCD anxiety disorders, depression). In line with this, a recent 
neurobiological study found that successful implementation of cognitive emotion 
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regulation strategies are associated with increased activation in the prefrontal brain 
regions (Levesque et al., 2004). In contrast, patients with OCD frequently exhibit deficits 
in the same brain regions, including the dorso-lateral prefrontal cortex (Menzies et al., 
2008; van den Heuvel et al., 2005). Despite the indicators for a relationship between 
OCD and dysregulation, as well as the recognition of its role in other childhood 
conditions (e.g., depression; Kovacs, Joormann, & Gotlib, 2008), dysregulation in 
pediatric OCD remains uninvestigated.   
Severity and Impairment in Pediatric OCD 
 Pediatric OCD is a heterogeneous condition with diverse symptomatic 
presentation.  Consequently, symptom severity, interference and distress from obsessive-
compulsive symptoms can vary by individual and functional domains. For example, 
contamination fears may lead some children to excessive washing and showering, and 
subsequently interfere in family functioning. For others, these same fears may 
differentially prompt social withdrawal and curbed participation in various normative 
activities.  Despite varied presentation, children with OCD consistently endorse distress 
and impairment in academic, familial, and socialization domains (Piacentini et al., 2007; 
Valderhaug & Ivarsson, 2005).  Additionally, comorbidity has been found to play a role 
in symptom severity and impairment. For example, children with OCD and non-OCD 
anxiety (e.g., social phobia) were found to have greater OCD symptom severity when 
compared to children with OCD alone (Storch et al., 2008a). For impairment, greater 
levels of anxiety, depression, and family accommodation were associated with elevated 
levels of impairment in pediatric OCD (Storch et al., 2010a). Counterbalancing these 
findings for internalizing disorders, children with OCD and a comorbid externalizing 
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disorder (e.g., ADHD) also reported greater OCD symptom severity, anxiety and 
impairment than children with OCD alone (Langley, Lewin, Bergman, Lee, & Piacentini, 
2010; Storch, Lewin, Geffken, Morgan, & Murphy, 2010c; Sukhodolsky et al., 2005).  
Given that dysregulation has been associated with the presence of severe 
psychopathology and impairment in non-clinical youth, youth with OCD and 
dysegulation may present with greater severity and impairment than youth with more 
regulated functioning.  Dysregulation shares aspects with constructs associated with 
elevated symptom severity (e.g., anxiety disorders), as well as impairment (e.g., ADHD, 
depression, externalizing disorders). Specifically for impairment, the construct of 
dysregulation may help account for disparate comorbid conditions implicated in 
impairment in pediatric OCD. Thus, the examination of dysregulation may serve as a 
potentially unifying dimension for the diverse constructs associated with symptom 
severity and impairment in pediatric OCD.  
Treatment of Pediatric OCD 
For children with OCD seeking treatment, cognitive-behavioral therapy (CBT) is 
a first line treatment that demonstrates considerable efficacy and produces moderate to 
large effect sizes (Abramowitz, Whiteside, & Deacon, 2005; POTS, 2004; Storch et al., 
2007). Components of CBT can include psycho-education, cognitive restructuring, 
parental involvement, with an emphasis on exposure with response-prevention. The 
exposure component requires children to repeatedly encounter situational and/or internal 
triggers to their anxiety that usually precipitate their compulsive behaviors. While 
confronting these exposures, patients must prevent from engaging in compulsions until 
habituation to the anxious state is achieved. Over repeated exposures, distress and its 
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associated desire to ritualize diminish. Recent conceptualizations of this behavioral 
model have suggested that emotional processing may play a role in fear reduction 
(Casado, Cobos, Godoy, Machado-Pinheiro, & Vila, 2011; Foa & Kozak, 1986). Emotion 
processing involves incorporation of new information into an existing structure that 
allows for either increased or decreased emotional responding (Foa & Kozak, 1986). The 
processing of pathological fear requires the activation of the fear structure and then the 
incorporation of corrective information.   
During emotional processing, dysregulation may affect physiological activation 
and habituation to stimuli—two components that are related to treatment outcomes (Foa 
& Kozak, 1986). For example, dysregulation in patients with OCD may result in impaired 
reactivity (or over-reactivity) in physiological responses to stimuli. Similarly, patients 
with dysregulation have difficulty regulating thoughts and emotions. Thus, youth with 
dysregulation may experience difficulty habituating to anxiety-provoking situations 
and/or incorporating corrective information. Habituation deficits may result in patients 
requiring longer therapeutic duration to achieve desired symptom reduction, or if present 
in a time-sensitive trial, may limit therapeutic response. Indeed, certain comorbidities 
(e.g., depression, disruptive behavior disorders) have been suggested to attenuate 
response to psychotherapy (Keeley, Storch, Merlo, & Geffken, 2008; Storch et al., 
2008b). Similar to findings for impairment, these comorbidity findings are inconsistent 
across treatment studies (Piacentini, Bergman, Jacobs, McCracken, & Kretchman, 2002); 
thus, these variable findings may indicate the presence of latent constructs (e.g., 
dysregulation) that influence treatment processes and therapeutic outcomes.  
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Beyond treatment outcomes, dysregulation may also play a role in two 
predominant issues confronting cognitive-behavioral therapies—patient attrition rates and 
homework compliance. Dysregulation levels may influence attrition rates as those 
patients with higher dysregulation may be more difficult to engage in treatment due to 
irritability or aggressive behaviors. These dysregulated patients may be more prone to 
discontinue treatment as opposed to their more regulated patients because of fluctuating 
moods and/or externalizing behaviors. Similarly, dysregulated youth may not engage in 
the therapeutic process, thereby limiting the overall benefit evidence-based treatment. 
Presently, there exists evidence of related constructs to dysregulation influencing existing 
attrition rates in treatment studies. For example, treatment studies of pediatric OCD 
(Franklin et al., 2011; POTS, 2004) have found attrition (between 13-16%) to be 
associated with high levels of OCD symptom severity, anxiety and depression (Aderka et 
al., 2011). Furthermore, research indicates that the presence of comorbid symptoms (e.g., 
oppositional behavior, attention difficulties, depression) commonly observed in OCD 
may also interfere with treatment by (Storch et al., 2008a). Aside from treatment attrition, 
dysregulation may also influence treatment outcomes though youth’s homework 
compliance.  Dysregulated youth may exhibit oppositional or non-complaint behaviors 
that make completion of assignments difficult. Furthermore, the inability to self-regulate 
anxious feelings may prohibit the completion of out-of-session practice exposures.  The 
ability to self-regulate is an important aspect in therapeutic processes with specific 
implications for attrition and homework compliance.  
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Present Study 
Dysregulation is a common problem affecting youth that is associated with 
deleterious outcomes. For youth with OCD, the presence of dysregulation may influence 
clinical presentation, impairment and treatment outcome. This study examines 
dysregulation in a large sample of youth with OCD with four primary objectives. First, 
this study examines whether children with OCD who meet categorical criteria for 
dysregulation, exhibit more severe psychopathology than children with OCD who do not 
meet dysregulation criteria.  It was hypothesized that dysregulated youth with OCD 
would exhibit more severe psychopathology than youth with OCD who had more 
regulated functioning. Second, this study examines whether a patient’s level of 
dysregulation predicts impairment rated by clinicians, parents and children above and 
beyond obsessive-compulsive severity. It was hypothesized that dysregulation would 
predict impairment rated by clinicians, parents and children above and beyond obsessive-
compulsive disorder. Third, this study explores whether dysregulation scores at baseline 
predict CBT outcome. It was hypothesized that baseline dysregulation levels would 
predict obsessive-compulsive severity at post-treatment and treatment outcome to CBT. 
Finally, as dysregulation has been suggested by some but not all to be a heritable and 
stable construct, this study investigates possible changes in dysregulation after receiving 
CBT. It was hypothesized that dysregulation would significantly decrease after CBT. 
Until now, no treatment studies have examined the influence of CBT on dysregulation in 
youth. If CBT does influence dysregulation, it may indicate a direction for future research 
and could be a considerable contribution to the field of child mental health.  
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METHOD 
Participants 
Participants were 144 youth (82 boys; 56%) ranging between 6-17 years of age 
(M = 12.61 years, SD = 2.81 years) who met diagnostic criteria for OCD. Participants 
were collectively recruited from one of two university-based specialty clinics for OCD in 
the state of Florida. Youth involved in this study agreed to participate in one of five 
studies (see Merlo, Lehmkuhl, Geffken, & Storch, 2009; Merlo et al., 2010; Storch et al., 
2011; Storch et al., 2008c; Storch et al., 2010d). Treatment outcome data after CBT was 
available for three of these studies (Merlo et al., 2009; Merlo et al., 2010; Storch et al., 
2011). Written consent was obtained from parents of children interested to participate, 
with assent being obtained from children as well. Inclusion and exclusion criteria were 
comparable across all studies, requiring participants to: (1) meet diagnostic criteria for 
OCD; (2) be medication free and/or on a stable dose of psychiatric medication; and (3) 
not have another psychiatric condition necessitating immediate treatment (for treatment 
studies). Children were not invited to participate if they did not meet the above criteria. 
For the treatment studies, children received structured CBT. Youth received no financial 
compensation for their participation. Collectively, this sample provided baseline data on 
144 participants with 97 of these participants receiving CBT (see Table 1).  Further 
demographic information concerning socioeconomic class, education and other 
demographic characteristics were unavailable for these participants. 
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Measures 
Anxiety Disorders Interview Schedule for DSM-IV– Child and Parent Version 
(ADIS-C/P): Silverman & Albano, 1996 The ADIS-C/P ( ) is a structured clinical 
interview that assesses current episodes of Axis I disorders and provides differential 
diagnosis based on DSM-IV-TR criteria (APA, 2000).  In youth between 7 and 17, the 
ADIS-C/P has consistently demonstrated strong psychometric properties, including test-
retest reliability, inter-rater reliability, and concurrent validity (Silverman, Saavedra, & 
Pina, 2001; Wood, Piacentini, Bergman, McCracken, & Barrios, 2002). Diagnostic 
categories of interest were OCD, ADHD, disruptive behavior disorders (e.g., oppositional 
defiant disorder, conduct disorder, intermittent explosive disorder), depressive disorders 
(e.g., major depression, dysthymia, depression-not otherwise specified), non-OCD 
anxiety disorders (e.g., generalized anxiety, social phobia, separation anxiety, specific 
phobia, panic disorder, agoraphobia),  substance disorders (e.g., substance use, substance 
dependence), body disturbance disorders (e.g., body dysmorphic disorder, anorexia), 
chronic tic disorder (e.g., Tourette Syndrome, chronic tic disorder), pervasive 
developmental disorder and bipolar disorder. This measure was completed as part of the 
screening procedure.  
Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS):
Scahill, Riddle, McSwiggin-Hardin, & Ort, 1997
 The CY-
BOCS is a 10-item semi-structured clinician-administered measure of current obsession 
and compulsion severity ( ).  The CY-
BOCS has demonstrated strong psychometric properties (e.g. inter-rater reliability, 
internal consistency, test-retest reliability, discriminant validity, convergent validity) in 
15 
 
youth between 4 and 18 years of age, and is considered the gold-standard measure for 
OCD severity in youth (Scahill et al., 1997; Storch et al., 2004). Total scores on this 
measure can range from 0 to 40. This measure was completed at baseline and post-
treatment assessment. 
Clinical Global Impression – Severity (CGI-S):
Storch et al., 2007
 The CGI-S is a 7-point clinician 
rating of psychopathology severity, which ranges from 0 (no illness) to 6 (extremely 
severe) (Guy, 1970). The CGI-S has been widely used in treatment studies and has 
demonstrated sound psychometric properties including convergent validity with the CY-
BOCS and treatment sensitivity ( ; Storch, Lewin, De Nadai, & 
Murphy, 2010b). The CGI-S was completed at baseline and post-treatment assessments. 
Clinical Global Impression of Improvement (CGI-I): 
Storch et al., 2010b
The CGI-I is a clinician-
rated measure of response to treatment on a 7-point Likert scale ranging from very much 
worse (0) to very much improved (6) (Guy, 1970).  A rating of very much improved (6) 
and much improved (5) are typically considered positive responses to treatment. Ratings 
of significant improvement on the CGI-I have been found to correspond with 25% 
reductions on the CY-BOCS ( ). The CGI-I was completed at the post-
treatment assessment.  
 13-Item Scale of Family Accommodation (FAS):
Calvocoressi et al., 
1995
 The FAS is a 13-item clinician-
rated questionnaire scored on a 5-point Likert-type scale that assesses the degree to which 
family members accommodate a child’s symptoms over a month (
). This measure has been found to be a good indicator of the level of 
distress/impairment that family members and patients experience, as a result of their 
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child’s obsessive-compulsive symptoms. The FAS was completed at baseline and post-
treatment assessments.  
Child Obsessive Compulsive Impact Scale– Parent/Child (COIS-P/C):
Piacentini et al., 2003
 The COIS-
P is a 56-item parent-rated questionnaire that examines OCD-related impairment in 
specific areas of child psychosocial functioning ( ). Each item is rated 
on a 4 point Likert-type scale: not at all (0), just a little (1), pretty much (2), and very much 
(3).  The complimentary measure for children (COIS-C) uses the same items and rating 
scales, but is completed by the child.  The COIS-C/P has good reliability and validity in 
children between 7 and 17 years of age.  The parent-and-child rated COIS were 
administered at baseline and post-treatment assessments. Only one participant in the 
sample (age 6) was not within the validated age range for this measure.  
Multidimensional Anxiety Scale for Children (MASC):
March, Parker, Sullivan, Stallings, & 
Conners, 1997
 The MASC is a 
psychometric 39-item self-report questionnaire that assesses symptoms of general, social, 
and separation anxiety in children and adolescents (
). Items are rated on a 4-point Likert-scale that ranges from never true (0) 
to often very true about me (3). A total score is computed by summing all items with 
higher scores corresponding to greater symptom severity. The MASC assesses child 
anxiety and has good reliability and validity in children between 8 and 17 years of age  
(March et al., 1997). The MASC was completed at both baseline and post-treatment 
assessments.  Only six participants in the sample (ages 6 to 7) were not within the 
validated age range for this measure. 
Children’s Depression Inventory (CDI):
Kovacs, 
 The CDI is a 10-item, brief child-
reported measure that assesses the presence/severity of depressive symptoms (
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1992). It is rated on a 3-point scale with higher scores indicating greater severity. The 
extensive use of the CDI in clinical and experimental research has provided ample data to 
support its reliability and validity  for children between 7 and 17 years of age (Kovacs, 
1992).  The CDI was completed at baseline and endpoint. Only one participant in the 
sample (age 6) was not within the validated age range for this measure. 
Child Behavior Checklist (CBCL):
Achenbach, 1991
 The CBCL is a widely used parent-rated 
questionnaire consisting of 118-items assessing the frequency of behavioral and 
emotional problems exhibited by children ( ). Each item is rated on a 3-
point Likert scale: not at all (0), sometimes (1), all the time (2). The CBCL produces 
eight clinical syndrome scales: withdrawn, somatic complaints, anxious-depressed, social 
problems, thought problems, attention problems, delinquent behavior, and aggressive 
behavior. Additionally, the CBCL produces broad-band Internalizing and Externalizing 
scales that largely correspond to mood and anxiety disorders, and disruptive behavior 
disorders, respectively. The CBCL has demonstrated good reliability, internal consistency 
and discriminant validity in youth between 4 and 18 years of age (Achenbach, 1991). In 
the present sample, the internal consistency of the CBCL syndrome scales ranged from 
0.59-0.90 (see Table 2). The Aggressive Behavior Syndrome Scale (20 items), Attention 
Problem Syndrome Scale (11 items) and Anxiety-Depression Syndrome Scales (14 items) 
are used in the calculation of the CBCL-Dysregulation Profile. The internal consistency 
of the CBCL-Dysregulation profile was .92. All participants completed the same version 
of the CBCL (1991 version) at baseline and post-treatment. Although completed on the 
1991 version, the high correlations between the raw scores on the problems scales of the 
18 
 
1991 and 2001 versions (r = .87-.99) suggest that findings would likely generalize across 
versions (Achenbach & Rescorla, 2001).  
Procedures 
 All independent evaluators underwent extensive training in the administration on 
clinician-rated measures (e.g., CY-BOCS, CGI-S and FAS). Training consisted of 
attending an instructional training meeting, observing multiple administrations of 
measures, and administering the measures multiple times with in vivo observation and 
supervision.  All participants completed an initial assessment that included a structured 
interview to assess current diagnoses (ADIS-C/P). Subsequently, clinicians assessed 
youth’s obsessive-compulsive symptom severity (CY-BOCS), level of family 
accommodation (FAS), and overall clinical severity (CGI-S). Parents completed forms 
evaluating their child’s behavior (CBCL), level of OCD-related impairment (COIS-P), 
and general demographics (e.g., children’s age, current medication, race, gender, etc). 
Children completed forms that assessed their level of anxiety (MASC), depression (CDI) 
and OCD-related impairment (COIS-C).  For participants receiving treatment, the above 
measures (excluding the diagnostic interview and impairment questionnaires) were re-
administered at a post-treatment assessment. In addition to these measures, a clinician 
completed a measure to evaluate global improvement of the participant (CGI-I). It is 
important to note that all evaluating clinicians were naive to the participant’s treatment 
condition. 
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ANALYTIC PLAN 
There have been various cut-off t-score on the CBCL used to indicate 
dysregulation. Initial studies relied on syndrome scale t-scores of 70 or greater on all three 
syndrome scales that correspond with clinical significance (Biederman et al., 1995), while 
others studies have relied upon t-scores of 60 or greater indicating borderline impairment 
(Meyer et al., 2009). Meanwhile, other studies have used the three syndrome scales to 
generate a composite score with dysregulation cut-offs varying between 180 and 210 
(Biederman et al., 2009; Spencer et al., 2011). Given that t-scores of 60 or greater are 
predictive of clinically significant psychopathology (Chen, Faraone, Biederman, & Tsuang, 
1994), this study utilized a t-score ≥ 65 on all three syndrome scales for the categorical 
comparison of dysregulation. T-score values ≥ 65 are indicative of clinically borderline 
symptoms indicate values 1.5 standard deviations above the mean, and falls in the range of 
scores previously used to indicate dysregulation. All power calculations were computed in 
G*Power 3.1 (Faul, Erdfelder, Lang, & Buchner, 2007). As no precedent was available 
for effect sizes, a medium-sized effect was assumed (based on criteria established by 
Cohen, 1988 and Lipsey & Wilson, 2001). 
In order to examine whether youth with OCD and dysregulation have more severe 
psychopathology than youth with OCD without dysregulation, an independent samples t-
test was conducted on continuous clinical characteristics for the sample of 144 youth. As 
20% of the sample was identified as meeting dysregulated criteria, a priori power analyses 
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identified a power of .85 to detect medium effects between groups.  Categorical 
characteristics were examined using Fisher’s exact tests statistic. As comorbid psychiatric 
conditions are often common in youth with OCD, Cohen’s κ statistic was used to examine 
classification agreement between youth who met categorical criteria for dysregulation and 
youth who met diagnostic criteria for both an internalizing disorder and externalizing 
disorder on the ADIS.  This comparison would discern whether categorical dysregulation 
was being accounted for by comorbid psychiatric conditions, or whether dysregulation 
itself was distinct. Internalizing disorders were considered to be generalized anxiety 
disorder, social phobia, separation anxiety, social phobia, panic disorder, agoraphobia, 
major depression, dysthymia, and depression not otherwise specified. Externalizing 
disorders were considered to be attention deficit hyperactivity disorder (ADHD), 
oppositional defiance disorder (ODD), conduct disorder, and intermittent explosive 
disorder. 
In order to examine the relationship between dysregulation and impairment, a 
hierarchical linear regression was completed to assess the unique contribution of 
dysregulation in predicting impairment scores, after accounting for the variance 
explained by obsessive-compulsive symptom severity. An a priori power analyses 
demonstrated that each hierarchical regression would have a power of .99 to detect a 
medium-sized effect. For these analyses, dysregulation was examined continuously rather 
than categorically using a revised CBCL-DP total score. For statistical analyses of these 
syndrome scales, the CBCL manual recommends the use of raw scale scores rather than 
t-scores to take into account the full range of variability (Achenbach, 1991). As each 
CBCL syndrome scale used a different number of items to contribute to the revised 
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CBCL-DP total score, syndrome scales were divided by the number of items used in its 
calculation. For example, the total syndrome score for attention problems consists of 11 
items, so that syndrome scale total score was divided by 11.These revised syndrome 
scores were summed to comprise a revised total score of the CBCL-DP, with values that 
ranged from 0 (no dysregulation) to 3 (extreme dysregulation). The revised CBCL-DP 
total score were used in three separate hierarchical linear regressions to examine whether 
dysregulation predicted clinician-rated illness severity (CGI-S), child-rated impairment 
(COIS-C) and parent-rated (COIS-P) impairment after accounting for variance explained 
by obsessive-compulsive severity (CY-BOCS). An exploratory hierarchical linear 
regression was conducted to examine whether dysregulation predicted family 
accommodation above and beyond obsessive-compulsive symptom severity. The 
variance inflation factor (VIF) was reported for all regression models to ensure the 
independent variables were not multi-collinear.  
The intent-to-treat principle was applied to participants who received CBT, 
whereby all treatment receiving participants were included in analyses. To examine the 
role of dysregulation in treatment, a bivariate regression was completed to determine 
whether the dysregulation total score (revised CBCL-DP total score) predicted the 
obsessive-compulsive severity (CY-BOCS total score) after treatment. A prior power 
analyses indicate a power of .92 to detect a medium-sized effect. Additionally, a logistic 
regression was conducted to examine whether baseline CBCL-DP total scores predicted 
the clinician’s rating treatment responder status using the CGI-I. A prior power analysis 
identified a power of .94 to detect a medium-sized effect. Additional exploratory logistic 
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regressions were completed to examine previously noted predictors of response (e.g., 
anxiety, depression, obsessive-compulsive symptom severity).  
In order to examine changes in dysregulation levels after CBT, a paired sample t-test was 
used to compare participants’ baseline and post-treatment revised CBCL-DP total score. 
A priori power analysis indicated a power of .99 to detect a medium-sized effect with a 
paired sample t-test. Following up on the significance of this test, a residualized change 
regression was used to determine if this change in dysregulation from baseline to 
endpoint was related to change in obsessive-compulsive symptom severity (CY-BOCS 
total score). Similar a priori power calculations indicated a power of .86 to detect a 
medium-sized effect. 
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RESULTS 
Sample Characteristics 
Demographic and clinical characteristics of the sample are provided in Table 1. 
Briefly, the sample was a relatively balanced mix of boys (57%) and girls (43%) who 
ranged in age from 6-17 years (M = 12.62 years, SD = 2.81 years).  Participants were 
predominantly Caucasian (81%) and all met diagnostic criteria for OCD (see Table 1). 
Sixty-six percent of participants were taking one or more serotonin reuptake inhibitor 
(SRI) medications. Comorbidity was common among participants, with the most frequent 
conditions consisting of non-OCD anxiety disorders (e.g., generalized anxiety disorder, 
social phobia, separation anxiety, social phobia, panic disorder, agoraphobia; 40%), 
ADHD (28%) and depressive disorders (e.g., major depression, dysthymia, depression 
not otherwise specified; 22%). Forty-seven percent of participants reported at least one 
co-occurring internalizing or externalizing disorder, with 22% of the sample presenting 
with both internalizing and externalizing disorders. Participants’ exhibited moderate 
obsessive-compulsive severity on the CY-BOCS (M = 26.24, SD = 4.65). There was a 
moderate relationship observed between obsessive-compulsive symptom severity and 
dysregulation at baseline, r = .43 p < .01.  No differences for gender were identified at 
baseline for obsessive-compulsive symptom severity, family accommodation, depressive 
symptoms, child-rated and parent-rated impairment. Gender differences were apparent 
for self-reported anxiety, with girls (M = 42.48 SD = 17.06) reporting themselves to be 
24 
 
more anxious than boys (M = 34.24, SD = 15.63), t(137) = 2.96, p < .01.  Table 2 
describes the relationship among the variables assessed in the sample using Pearson’s 
correlations.  
Table 1.  Clinical and Demographic Characteristics of the Sample (N=144)  
 N (%) 
Male  82 (57%) 
Female  62 (43%) 
Race    
   White/Caucasian  118 (81%) 
   Black/African American  6 (4%) 
   Asian/Asian American  5 (4%) 
   Hispanic/Latino  8 (6%) 
   Biracial/ Other  7 (5%) 
Comorbid Psychiatric Conditions    
  ADHD  40 (28%) 
  Disruptive Behavior Disorder  25 (17%) 
  Depressive Disorder  32 (22%) 
  Non-OCD Anxiety Disorder  58 (40%) 
  Body Dysmorphia or Eating Disorder  2 (1%) 
  Tic Disorder  10 (7%) 
  Pervasive Developmental Disorder  2 (1%) 
  Bipolar Disorder  1 (< 1%) 
Comorbidity Groupings   
OCD + Internalizing Disorder  26 (18%) 
OCD + Externalizing Disorder 42 (29%) 
OCD + Internalizing + Externalizing 
Disorder 
31 (22%) 
Medication Status   
On a SSRI and/or SRI  95 (66%) 
 N  Mean (SD) 
  Age   144 12.62  (2.81) 
  CY-BOCS Total Score  144 26.24 (4.65) 
  MASC Total Score  136 7.45 (3.96) 
  CDI Total Score  139 37.74 (16.70) 
  COIS-C Total Score  132 40.96 (29.28) 
  COIS-P Total Score  122 48.34 (30.54) 
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Table 2.   Pearson Correlations on Measures of Psychological Functioning     
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. CY-BOCS Total Score .82                 
2. FAS Total Score .47** .90                
3. CDI Total Score .23** .25** .73               
4. MASC Total Score .28** .01 .13 .90              
5. COIS-C Total Score .47** .40** .27** .38** .96             
6. COIS-P Total Score .52** .55** .30** .20* .67** .96            
7. CBCL Withdrawn  .43** .30** .29** .24** .39** .63** .77           
8. CBCL Somatic Complaints .21* .26** .08 .28** .37** .33** .36** .72          
9. CBCL Anxious Depressed .36** .30** .27** .41** .40** .50** .66** .38** .80         
10. CBCL Social Problems .28** .25** .21* .19* .33** .41** .46** .30** .37** .69        
11. CBCL Thought Problems .37** .27** .00 .17* .41** .49** .48** .38** .46** .40** .59       
12. CBCL Attention Problems .41** .31** .19* .20* .38** .58** .53** .29** .49** .66** .45** .82      
13. CBCL Delinquent Behavior .25** .46** .26** .18* .33** .38** .37** .25** .41** .40** .30** .46** .67     
14. CBCL Aggressive Behavior .28** .47** .26** .04 .27** .45** .38** .20* .47** .48** .30** .50** .69** .90    
15. CBCL Internalizing Scale .26** .41** .30** .30** .39** .53** .67** .55** .79** .46** .48** .51** .48** .57** .87   
16. CBCL Externalizing Scale .40** .43** .26** .18* .36** .49** .52** .32** .58** .47** .35** .54** .76** .86** .45** .91  
17. CBCL-Dysreg Profile .43** .44** .30** .26** .44** .62** .64** .36** .79** .63** .50** .83** .64** .81** .76** .80** .92 
*p < .05; **p < .01 Note: Cronbach’s Alpha is present for each measure along the diagonal.  
 CY-BOCS = Children’s Yale-Brown Obsessive Compulsive Scale; FAS = 13 item scale of Family Accommodation; CDI = Child Depression Inventory; MASC = 
Multidimensional Anxiety Scale for Children; COIS-C = Child Obsessive-Compulsive Impact Scale- Child report; COIS-P = Child Obsessive-Compulsive Impact 
Scale- Parent report; CBCL = Child Behavior Checklist 
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Categorical Dysregulation and Clinical Severity 
Twenty-nine youth (20%) with OCD met categorical criteria for dysregulation 
(see Table 3). It was hypothesized that dysregulated youth who have more severe 
psychopathology than youth without dysregulation.  As hypothesized, dysregulated youth 
had greater obsessive-compulsive symptom severity (p < .01), and greater overall clinical 
severity on the CGI-S (p < .01) compared to youth with more regulated functioning.  
Additionally, both children (p < .01) and parents (p < .01) reported that dysregulated 
youth experienced greater levels of impairment (see Table 2). Compared to youth with 
more regulated functioning, dysregulated youth had higher scores on several of the 
CBCL syndrome scales including the Withdrawn scale (p < .01), Social Problem scale (p 
< .01), Thought Problem scale (p < .02) and Delinquent Behaviors scale (p < .01).  Level 
of family accommodation was greater in dysregulated youth compared to families with 
children who had more regulated functioning (p < .01, see Table 2). Finally, youth with 
dysregulation exhibited greater levels of self-reported depressive symptoms (p < .01) but 
did not have higher levels of self-reported anxiety symptoms (p > .15).  For those youth 
diagnosed with an internalizing and externalizing disorder (N = 31), 12 youth (39%) met 
categorical criteria for dysregulation. For youth who did not meet criteria for both an 
internalizing and externalizing disorder on the ADIS (N = 113), 17 youth (15%) met 
categorical criteria for dysregulation. The κ coefficient was .24 (p < .01) suggesting poor 
agreement between categorization as dysregulation and the presence of an internalizing 
and externalizing disorder (Fleiss, 1981). The minimal agreement suggests that 
dysregulation cannot be fully accounted for by these broad diagnostic categories.  
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Table 3.  Comparison of Dysregulated and non-Dysregulated Youth 
 Children without 
Dysregulation (n = 115)  
Children with Dysregulation  
(n = 29)  
χ² p 
Male  69 (60%)  13 (45%)  2.18 .14 
Comorbid Psychiatric Conditions  
ADHD  25 (22%)  15 (52%)  15.08 <.01 
Disruptive Behavior 
Disorder  
14 (12%)  11 (40%)  10.71 <.01 
Depressive Disorder  19 (17%)  13 (45%)  10.74 <.01 
Non-OCD Anxiety 
Disorder  
45 (39%)  13 (45%)  .31 .67 
Body Dysmorphia or 
Eating Disorder  
2 (2%)  0 (0%)  Fisher’s 
exact test 
1.0 
Tic Disorder  6 (5%)  4 (16%)  2.64 .10 
Pervasive Developmental 
Disorder  
2 (2%)  0 (%)  Fisher’s 
exact test 
1.0 
Bipolar Disorder  1 (1%)  0 (0%)  Fisher’s 
exact test 
.60 
Collective Comorbid Conditions      
OCD +  Internalizing 
Disorder 
35 (30%)  7 (24%)  .44 .51 
OCD + Externalizing 
Disorder 
17 (15%)  9 (31%)  4.13 .04 
OCD + Internalizing 
+Externalizing Disorder 
19 (17%)  12 (41%)  8.47 <.01 
Medication Status 
On a SSRI and/or SRI  75 (65%)  20 (69%)  .15 .70 
 N Mean (SD) N Mean (SD) t p 
Age  115 12.44 (2.84) 29 13.31 (2.58) -1.49 .14 
OC-Severity  
CY-BOCS Total Score  115 25.63 (4.42) 29 28.69 (4.79) -3.28 <.01 
CGI-Severity 112 3.85 (0.90) 28 4.43 (0.88) 3.06 <.01 
Comorbidity Severity        
MASC Total Score  112 36.72 (15.54) 25 41.94 (20.64) -1.46 .15 
CDI Total Score  110 6.87 (3.85) 26 9.91 (3.47) -3.69 <.01 
Family Accommodation 
Total Score  
111 24.04 (10.48) 29 32.62 (13.62) -3.68 <.01 
Impairment        
COIS-C Total Score  109 36.97 (27.60) 23 59.88 (30.21) -3.56 <.01 
COIS-P Total Score  98 40.76 (23.72) 24 79.28 (35.92) -6.38 <.01 
Child Behavior Checklist Raw Scores      
Withdrawn  113 3.38 (2.90) 29 6.10 (3.10) -4.44 <.01 
Somatic  114 2.82 (2.76) 29 3.56 (3.38) -1.23 .22 
Social Problems  115 3.43 (2.83) 29 6.31 (2.48) -5.01 <.01 
Thought Problems  112 4.77 (2.29) 28 5.95 (2.58) -2.39 .02 
Delinquent Behaviors  115 1.86 (2.20) 29 4.88 (2.76) -6.26 <.01 
Internalizing Scale  115 14.04 (7.64) 29 24.92 (9.60) 6.49 <.01 
Externalizing Scale  112 10.78(8.67) 29 25.21 (7.15) 8.27 <.01 
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Dysregulation and Impairment 
It was hypothesized that dysregulation would predict impairment rated by 
clinicians, parents and children above and beyond obsessive-compulsive disorder. Three 
separate hierarchical regressions were conducted to examine the role of dysregulation on 
obsessive-compulsive symptom severity and impairment. Excessive collinearity between 
the two independent variables used in these regression analyses was not observed (see 
Table 2) and variance inflation factors (VIF) for all regression analyses were low. For 
overall clinical severity, step 1 of the hierarchical linear regression revealed that 
obsessive-compulsive symptom severity predicted overall clinician-rated severity and 
explained 59% of the variance (see Table 4). The incorporation of dysregulation in step 2 
of the model did not add significantly to the model and explained less than 1% of 
additional variance (p = .63; see Table 4).  
Table 4. Predictors of Clinician-rated Severity on the CGI-S  
Variable B SE B β t value p value VIF 
Step1       
CY-BOCS Total Score  .15 .01 .77 14.06 <.01 1.00 
Step 2       
CY-BOCS Total Score .15 .01 .76 12.46 <.01 1.23 
CBCL-DP Total Score .03 .06 .03 0.48 .63 1.23 
Model fit statistics:   
Step 1: R2 = .59, p < .01 
Step 2: R2 = .59, ΔR2 = < .01, p = .63 
 
 
For child-rated impairment, step 1 of the hierarchical linear regression identified 
that obsessive-compulsive symptom severity predicted child-rated impairment and 
explained 22% of the variance (see Table 5). When dysregulation was added to the model 
in step 2, it significantly improved the model (p < .01) and accounted for an additional 
29 
 
7% of variance in child-rated impairment (see Table 5). Thus, these findings suggest that 
dysregulation predicts child-rated impairment beyond obsessive-compulsive symptom 
severity.  
Table 5. Predictors of child-rated Impairment on the COIS  
Variable B SE B β t value p value VIF 
Step1       
CY-BOCS Total Score  2.97 0.49 .47 6.08 <.01 1.00 
Step 2       
CY-BOCS Total Score 2.20 0.52 0.35 4.25 <.01 1.22 
CBCL-DP Total Score 8.82 2.52 0.29 3.50 <.01 1.22 
Model fit statistics:   
Step 1: R2 = .22, p < .01 
Step 2: R2 = .29, ΔR2 = .07, p < .01 
 
For the examination of parent-rated impairment, a similar pattern of findings 
emerged. Step 1 of the hierarchical linear regression identified that obsessive-compulsive 
symptom severity predicated parent-rated impairment and explained 27% of variance (see 
Table 6). When dysregulation was added to the parent-rated impairment model in step 2, 
it significantly improved the model (p < .01) and accounted for an additional 20% of 
variance. These findings suggest that dysregulation predicts parent-rated impairment 
beyond obsessive-compulsive symptom severity (see Table 6).   
Table 6. Predictors of parent-rated Impairment on the COIS  
Variable B SE B β t value p value VIF 
Step1       
CY-BOCS Total Score  3.46 .52 .52 6.62 <.01 1.00 
Step 2       
CY-BOCS Total Score 2.09 .49 .31 4.28 <.01 1.21 
CBCL-DP Total Score 15.52 2.30 .50 6.75 <.01 1.21 
Model fit statistics:   
Step 1: R2 = .26,  p < .01 
Step 2: R2 = .47,  ΔR2 = .20, p < .01 
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Additionally, an exploratory hierarchical linear regression was completed to 
investigate the relationship between family accommodation and dysregulation. For this 
model of clinician-rated family accommodation, step 1 identified that obsessive-
compulsive symptom severity predicted family accommodation and explained 22% of 
variance (see Table 7). When dysregulation was added to the model, it significantly 
improved the model (p < .01) and accounted for an additional 7% of variance. Thus, it 
appears that dysregulation predicts family accommodation beyond obsessive-compulsive 
symptom severity (see Table 7). 
Table 7. Predictors of Family Accommodation on a 13-item clinician-rated scale  
Variable B SE B β t value p value VIF 
Step1       
CY-BOCS Total Score  1.21 .19 .47 6.32 <.01 1.00 
Step 2       
CY-BOCS Total Score .89 .20 3.48 4.37 <.01 1.23 
CBCL-DP Total Score 3.48 .96 .29 3.63 <.01 1.23 
Model fit statistics:  
Step 1: R2 = .22, p < .01 
Step 2: R2 = .29, ΔR2 = .07, p < .01 
 
 
Dysregulation and Attrition 
Attrition for CBT was 18% (n = 15), which is comparable to other treatment 
studies for childhood OCD (Franklin et al., 2011; POTS, 2004). Youth who did not 
complete treatment and/or did not complete the post-treatment assessment exhibited 
significantly greater baseline dysregulation (M = 2.43, SD = 0.97) than treatment 
completers (M = 1.83, SD = 0.90), t(95) = -2.33, p < .02. Additionally, these youth also 
exhibited significantly greater scores on the CBCL Externalizing Scale (p < .01). No 
other significant differences on available measures were identified. 
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Baseline Dysregulation and Treatment Response 
Using the intent-to-treat principle for those 97 participants who received CBT, a 
significant decrease in obsessive-compulsive symptom severity was observed from 
baseline (M = 26.09, SD = 5.04) to post-treatment (M = 13.78, SD = 9.41), t(96) = 13.10, 
p < .01. On average, CBT had a large effect size (Cohen’s d = 1.33) with participants 
displaying a significant decrease in obsessive-compulsive symptom severity (M = 12.31, 
SD = 9.26). Overall, 67 (69%) participants exhibited a response to treatment on the CGI-
I.  It was hypothesized that baseline dysregulation levels would predict obsessive-
compulsive severity at post-treatment and treatment outcome to CBT. Although 
approaching significance, a bivariate regression revealed that baseline dysregulation (B = 
1.91, SE B = 1.01, β = .19, t = 1.89) did not account for obsessive-compulsive symptom 
severity at post-treatment ( R² = 0.04, F (1, 96) = 3.56, p = .06). Further investigations 
into the association between treatment response on the CGI-I and baseline dysregulation 
were completed using a binary logistic regression. Participant response to treatment was 
the dependent variable and baseline dysregulation was entered as the independent 
variable. The dysregulation at baseline did not predict dichotomous treatment response on 
the CGI-I (odds ratio [OR] = 0.90, 95% CI = 0.57- 1.42, Wald = 0.21, p = .65).  
Furthermore, exploratory binary logistic regressions revealed that neither baseline anxiety 
symptoms (OR = 1.01, 95% CI = 0.98-1.04, Wald = 0.68, p = .41), depressive symptoms 
(OR = 1.10, 95% CI = 0.98-1.23, Wald = 2.48, p = .12) or obsessive-compulsive severity 
(OR = 0.99, 95% CI = 0.91-1.09, Wald = .02, p = .90) predicted dichotomous treatment 
response.  
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Influence of CBT on Dysregulation 
It was hypothesized that dysregulation would significantly decrease after CBT. 
For those youth who completed treatment (n = 84), a paired samples t-test identified a 
significant decrease in youth’s dysregulation from baseline (M = 1.86, SD = 0.94) to post 
treatment (M = 1.36, SD = 0.85), t(71) = 6.58, p < .01. Following up on this difference, a 
residualized change regression was conducted to examine the relationship between the 
change between dysregulation and obsessive-compulsive symptom severity after 
treatment. First, it was identified that baseline dysregulation significantly predicted post-
treatment levels of dysregulation, t(71) = 9.47, p < .01 (see Table 8). Similarly, baseline 
obsessive-compulsive severity significantly predicted post-treatment levels of obsessive-
compulsive symptom severity, t(81) = 2.05, p < .04 (see Table 8).  
Table 8.  Residualized Change Regression for Dysregulation and CY-BOCS 
 B  SE (B)  β  95% CI  
CBCL-DP     
Constant  0.10  0.15   
CBCL-DP Total Score * 0.68 0.07 0.75 0.54 - 0.82 
CY-BOCS     
Constant  2.08 4.64   
CY-BOCS Total Score ** 0.36 0.18 0.22 0.01- 0.71 
*R2= 0.56, SE= 0.57 
** R2= 0.50, SE= 7.71 
 
When the residual change in dysregulation was correlated with the residual 
change in obsessive-compulsive symptom severity, a small to moderate significant 
relationship was observed, r(72) = 0.36, p < .01.  
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Table 9.  Predictors of residual change on the CBCL-DP 
 B  SE (B)  β  T p-value 95% CI  
Constant  -.59 .40     
FAS Total Score .02 .01 2.28 2.27 .03 .003 - .05 
CDI Total Score .01 .03 .04 .34 .74 -.05 - .08 
MASC Total Score < .-01 . < .01 -.03 -.25 .80 -.02 - .01 
F (3,64) = 2.00, p = .12 
R2 = 0.09, SE = 0.99 
 
Neither baseline anxiety nor depression was identified as a significant predictor of 
the change observed in dysregulation and obsessive-compulsive symptom severity (see 
Table 9 & 10).  Interestingly, baseline family accommodation predicted the level of 
change of dysregulation (see Table 9) but not change in obsessive-compulsive symptom 
severity (see Table 10).  
Table 10.  Predictors of Residual Change on the CY-BOCS 
 B  SE (B)  β  T p-value 95% CI  
Constant  -.19 .39     
FAS Total Score .01 .01 .16 1.35 .18 -.007 - .03 
CDI Total Score < .01 .03 . < .01 .01 .99 -.06 - .06 
MASC Total Score < -.01 < .01 -.07 -.62 .54 -.02 - .01 
F (3,72) = .784, p = .50 
R2 = 0.03, SE = 0.98 
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DISCUSSION  
The current study examined the role of dysregulation in the clinical presentation 
and treatment outcomes of pediatric OCD. Consistent with previous research in non-
clinical populations (e.g., Meyer et al., 2008), dysregulated youth with OCD were found 
to have more severe symptomology and greater overall severity than non-dysregulated 
youth.  More specifically, dysregulated youth had greater obsessive-compulsive severity, 
impairment, family accommodation, anxiety and depression. These data suggest that 
youth with dysregulation and OCD exhibit a more complex and severe symptom profile 
than youth without dysregulation.  For youth with OCD, obsessional worries trigger 
distress, which motivates the performance of compulsive behaviors that serve to 
temporarily alleviate anxiety. When confronting these situations and/or prevented from 
completing anxiety-reducing compulsive behaviors, dysregulated youth may experience 
more frustration and exhibit  disruptive behaviors and emotional outbursts in response to 
these encounters. As such disruptive behaviors and outbursts increase the burden 
experienced by parents, it is not surprising that parents may be more willing to 
accommodate obsessive-compulsive behaviors in lieu of confronting a situation that 
results in a disruptive outburst, resulting in the observed increased levels of family 
accommodation.   
From a neurobiological perspective, youth with dysregulation may have deficits 
in brain functioning that result in impaired regulatory functioning and elevated sensitivity 
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to stimuli, beyond that present in youth with OCD alone. Additionally, dysregulated 
youth may be highly attuned to their surroundings and may experience dysregulated 
mood and behaviors even in the presence of minimal anxiety-provoking stimuli.  While 
there are likely several different causes for the manifestation of dysregulated behaviors in 
youth with OCD, its presentation, regardless of the cause, results in a more severe 
symptom profile compared to those with OCD alone. As such, dysregulated youth are 
often more difficult to treat, and may require comprehensive treatment to address 
dysregulated behaviors as well as obsessive-compulsive symptoms.  
Similar to previous examinations that reported impaired psychosocial functioning 
in clinical (Biederman et al., 2009) and non-clinical samples (Meyer et al., 2009), 
dysregulation predicted the level of impairment experienced by youth with OCD. 
Specific to pediatric populations with OCD, dysregulation predicted parent-and-child-
rated impairment above and beyond obsessive-compulsive symptom severity. While 
obsessive-compulsive symptoms are impairing and likely serve as the primary reason for 
seeking treatment, dysregulation appears to account for additional functional impairment. 
It is important to note that these findings apply to all youth with OCD, and not just those 
exhibiting threshold levels of dysregulation.  While dysregulation is associated with 
impaired psychosocial functioning and functional impairment, comprehensive 
interventions that target both dysregulation and obsessive-compulsive symptoms may 
reduce the elevated impairment experienced by children and families. Interestingly, 
dysregulation also predicted family accommodation beyond obsessive-compulsive 
severity. It may be that youth with higher dysregulation have more difficulty with day-to-
day activities due to their inability to regulate emotions and/ or behaviors. As a result, 
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these youth may rely on family members to facilitate their functioning compared to youth 
with more regulated functioning. Alternatively, parents may be more likely to 
accommodate obsessive-compulsive behaviors in lieu of potential disruptive behavioral 
outbursts.  As family accommodation is recognized as a critical factor in treatment for 
youth with OCD (Merlo et al., 2009), it is imperative to understand the complex 
relationship between dysregulation and family accommodation. Future research should 
examine the temporal order between dysregulation and family accommodation.  
Exposure-based CBT had a large effect on participants’ obsessive-compulsive 
symptom severity (Cohen’s d = 1.33), with 69% of participants considered responders to 
treatment. Although approaching significance, baseline dysregulation did not predict 
post-treatment obsessive-compulsive severity. Furthermore, baseline dysregulation did 
not predict treatment response status, and baseline anxiety, depression and obsessive-
compulsive severity were not identified as predictors of treatment response status. 
Consistently identifying predictors of treatment response in pediatric OCD is challenging, 
as examinations of predictive characteristics are often subject to methodological 
limitations and/or post-hoc approaches (Ginsburg, Kingery, Drake, & Grados, 2008).  
That being said, externalizing symptoms, disruptive behaviors (e.g., ADHD, ODD), 
major depression and OCD-related impairment have been noted to attenuate treatment 
response to CBT in previous studies (Garcia et al., 2010; Piacentini et al., 2002; Storch et 
al., 2008b). These constructs are all related to dysregulation, thereby suggesting that 
dysregulation may play a role in treatment response. Nevertheless, the findings from the 
present study suggest that a predictive relationship between dysregulation and treatment 
outcome is at best modest in strength. As dysregulation is a continuous measure, there 
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may be a threshold on this spectrum that results in attenuated response to CBT. 
Alternatively, it may be that the effect of dysregulation on treatment outcome was more 
modest than originally hypothesized (medium effect size), and thus the sample was 
underpowered.  
While dysregulation does not appear to attenuate treatment outcome, it does 
appear to play an influential role in treatment attrition. For the 97 participants who 
received CBT, 18% dropped out of treatment. Although rationale for discontinuation was 
not elicited, several clinical factors were examined to discern differences between youth 
who completed treatment and those who discontinued early. Notably, baseline 
dysregulation and externalizing behaviors emerged as a predictor of treatment 
discontinuation. Careful screening and attention should be paid to youth prior to initiating 
treatment, as this may identify patients more likely to discontinue, and can guide 
clinicians in making more individualized treatment recommendations.  For dysregulated 
youth, these individualized recommendations may include unique therapeutic delivery 
modalities (e.g., intensive daily CBT) that limit attrition. Alternatively, it may be more 
useful to treat dysregulated behaviors with targeted interventions prior to starting CBT 
for obsessive-compulsive symptoms. For example, parent training  has demonstrated 
preliminary evidence in reducing disruptive behaviors present in youth with OCD (Ale & 
Krackow, 2011; Lehmkuhl et al., 2009). Indeed, the early utilization of these therapies 
may provide children and parents with the skills needed to manage the disruptive 
behaviors and emotional outbursts that impede exposure-based CBT.   
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Exposure-based CBT necessitates youth to confront their obsessional triggers and 
parents to engage in less accommodation of obsessive-compulsive symptoms. As 
accommodation decreases, youth have to face anxiety-provoking stimuli in the absence of 
mitigating compulsive behaviors.  As these situations are often difficult for youth without 
dysregulation, they may be more likely to elicit emotional outbursts and disruptive 
behaviors in dysregulated youth.  Youth and parents who learn to appropriately manage 
disruptive behaviors and emotional outburst prior to CBT, may be less likely to have 
these outbursts interfere with treatment. Without such outbursts impeding therapeutic 
progress, children and parents may be more likely to complete the full course of 
treatment and experience reduction in obsessive-compulsive symptom severity.    
When assessing youth after treatment, a novel finding emerged. Despite previous 
findings that dysregulation is a stable construct over time (Boomsma et al., 2006; Meyer 
et al., 2009), it appeared that CBT produced a significant decrease in dysregulation. This 
finding suggests that cognitive-behavioral interventions can yield reductions in 
dysregulation, which may subsequently curtail the development of severe 
psychopathology observed in long-term follow-up studies (Althoff et al., 2010; Meyer et 
al., 2009).  While dysregulation has historically been conceptualized as a trait, this 
research suggests that it is a malleable construct that is responsive to behavioral 
interventions. While these gains were observable post-treatment, future research should 
examine whether these positive gains persist over time, or whether this reduction in 
dysregulation reverts back to its pre-treatment levels over time.  
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Interestingly, a small to moderate relationship emerged between the change in 
dysregulation and the change in obsessive-compulsive symptom severity. It may be that 
as youth develop control over compulsive behaviors through CBT, the enhanced 
behavioral control is generalized to other dysregulated behaviors. From a neurobiological 
perspective, increasing an individual’s regulatory abilities through CBT may produce 
improved functioning in regions associated with self-regulation. Findings from brain 
imaging studies in patients with OCD who receive CBT support this hypothesis. Studies 
measuring the effects of CBT for OCD on state glucose metabolism or blood flow 
showed decreases in activity of previously overly activated areas (Baxter, Schwartz, 
Bergman, & Szuba, 1992; Nakatani et al., 2003; Schwartz, Stoessel, Baxter, Martin, & 
Phelps, 1996). Furthermore, correlations between activity in the caudate, orbitofrontal 
cortex and the thalamus identified prior to treatment were not observed after treatment 
(Baxter et al., 1992; Linden, 2006; Schwartz et al., 1996). Improvement in these areas 
may also generalize to related brain regions involved in emotional regulation (e.g., 
prefrontal cortex).  Aside from these hypothesized neurobiological mechanisms of 
changes, these findings highlight that youth who completed treatment experienced 
improvement in both dysregulation and obsessive-compulsive symptoms.   
Limitations and Implications 
This study had several limitations.  First, the study was limited in scope due to the 
combination of archival datasets.  As there was limited availability of shared measures 
across datasets, some aspects of obsessive-compulsive phenomenology (e.g., symptom 
dimensions) remained unexamined. The present findings should be further investigated 
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and replicated in future prospective studies. Second, findings may have been hindered by 
the use of a single parent-reported measure of dysregulation. While prior studies have 
relied upon parent-reported ratings alone (e.g., Althoff et al., 2010; Biederman et al., 
1995), future research may benefit from the collection of multiple measures of 
dysregulation (e.g., physiological measure, teacher reports, etc). Third, the sample was 
predominantly Caucasian, which may limit the extent to which findings generalize to the 
larger population of youth with OCD. Fourth, there was no control group in which to 
examine the change in dysregulation in the absence of treatment.  While previous studies 
have shown dysregulation to be stable across time, it would prove more beneficial to 
examine the change in dysregulation in a parallel wait-list condition.  While the changes 
in dysregulation likely resulted from the therapeutic intervention, it may also have 
resulted from a typical a waxing and waning of dysregulated symptoms.  Finally, inherent 
limitations of available instruments to measure constructs of interest may have affected 
these findings. More specifically, while the CY-BOCS total score serves as a measure of 
symptom severity, these scores are based, in part, on the extent to which symptoms 
interfere with social activities and/or school performance. This may have resulted in an 
inadvertent inflation in the relationship between symptom severity and impairment, 
thereby decreasing the amount of variance explained by adding other variables to the 
regression models.  Counterbalancing this concern was the finding that the relationship 
between dysregulation and impairment remained significant, with dysregulation 
predicting impairment beyond that of OCD severity.  
Despite these noted limitations, the findings from this study have several 
important implications for both research and clinical practice.  Youth identified with 
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dysregulation and OCD exhibit greater impairment and severity than youth with OCD 
and more regulated functioning.  Additionally, dysregulation predicted child-and-parent-
rated impairment beyond that of OCD severity. As dysregulation parallels obsessive-
compulsive symptoms, it is important for clinicians to gauge dysregulation prior to 
initiating treatment.  Even when not readily recognizable, dysregulation should be further 
queried as dysregulated symptoms may be mitigated by family accommodation. Overall, 
the timely recognition of dysregulation can serve to guide the treatment planning process. 
More specifically, the complex and impairing nature of dysregulation and OCD may 
require the initial treatment of dysregulated symptoms prior to addressing obsessive-
compulsive problems.  As dysregulation was associated with treatment dropout, the 
initially treatment of dysregulated behaviors would likely reduced treatment 
discontinuation.  Indeed, addressing dysregulated behaviors prior to initiating CBT may 
not only help youth stay in treatment, but it can also lead to the achievement of 
meaningful symptom reduction.   
For those youth who completed treatment, a substantial decrease in obsessive-
compulsive severity was observed.  Furthermore, a moderate and significant relationship 
emerged between the decrease in obsessive-compulsive severity and dysregulation. These 
findings indicate the utility of exposure-based CBT to treat dysregulation as well as 
obsessive-compulsive symptoms.  Beyond reducing obsessive-compulsive symptoms, 
these findings demonstrate that dysregulation can be responsive to exposure-based CBT, 
which may be attributed to its strengthening of youth’s self-regulatory abilities. In turn, 
this enhanced ability to self-regulate, reduces both dysregulated behaviors and obsessive-
compulsive symptoms.  As dysregulation was initially considered to possess a stable 
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trait-like quality associated with the later development of severe psychopathology, these 
findings suggest that the delivery of CBT and adjunctive therapies (e.g., parent training, 
anger-control training) may curb the development of later severe and impairing disorders 
for these youth.  
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